SCHEMBL6529680

SCHEMBL6529680

COc1ccc(Sc2nc(NCC(OC)OC)nc(Nc3cccc(F)c3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH3 Q9ULD8 6/20 0.43
CHRNA7 P36544 2/20 0.42
MAPT P10636 2/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RAD52 P43351 1/20 0.41
APP P05067 2/20 0.39
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
KDM4E B2RXH2 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6529816 0.85 KCNH3 (0.43) KCNH3CHRNA7MAPTTP53POLB
SCHEMBL6530945 0.84 KCNH3 (0.59) KCNH3CHRNA7MAPTTP53POLB
SCHEMBL6531533 0.83 CA12 (0.45) KCNH3CHRNA7MAPTTP53POLB
SCHEMBL6529150 0.81 CHRNA7 (0.61) CHRNA7MAPTTP53POLBMEN1
SCHEMBL6530404 0.79 IDH2 (0.43) KCNH3CHRNA7MAPTTP53POLB
SCHEMBL6527570 0.79 IDH2 (0.43) KCNH3CHRNA7MAPTTP53POLB
SCHEMBL6528931 0.77 KCNH3 (0.41) KCNH3CHRNA7MAPTTP53POLB
SCHEMBL6508189 0.77 KCNH3 (0.41) KCNH3CHRNA7MAPTTP53POLB
SCHEMBL6528850 0.77 AAK1 (0.42) CHRNA7MAPTTP53POLBMEN1
SCHEMBL6528847 0.77 SYK (0.43) KCNH3CHRNA7MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed